[4] However, Mounjaro has a higher average weight loss, with one clinical study finding it could reduce your weight by up to 20.9% over 72 weeks on the maximum dose
(3) reduced appetite and increased control of eating behaviours
Critical Considerations: This schedule is purely theoretical and not based on clinical evidence Individual tolerance varies dramaticallysome may not tolerate even these conservative doses Maximum combined doses would likely need to remain below monotherapy maximums (perhaps 2.4 mg cagrilintide + 8 mg retatrutide as absolute ceiling) Medical supervision would be essential throughout any such protocol Alternative Approach: Sequential Rather Than Concurrent An arguably safer alternative to simultaneous cagrilintide dosage with retatrutide administration involves sequential optimization: Optimize one compound first Reach stable, effective dose of either cagrilintide or retatrutide Assess response Evaluate metabolic effects over 12-16 weeks Introduce second compound Only if additional effects are needed Ultra-gradual second titration Even slower escalation of the added compound Continuous reassessment Regular evaluation of whether combination provides benefits beyond monotherapy This approach provides clearer attribution of effects and side effects to specific compounds, though it significantly extends the overall timeline
The pharmacokinetic profiles differ enough that what worked for one may need adjustment for the other
By triggering GLP-1 and GIP receptors in other tissues, tirzepatide also slows down digestion and suppresses appetite, helping patients achieve significant weight reduction [6, 7, 8]
It's also frequently misrepresented - used to make promises about compounded products that the original trials don't support
